With the analysis among 2,790 patents, we discovered top 455 key players by total patent application. Bristol Myers Squibb Co., Histide AG, Novartis AG are dominant in this area. They take 14.48% of the total patent filing.
New York, United States
Patent: 225
Schwyz, Switzerland
Patent: 91
Basel-Stadt, Switzerland
Patent: 88
MethylGene, Inc. (Canada)
New York, United States
Patent: 72
California, United States
Patent: 56
New Jersey, United States
Patent: 40
F. Hoffmann-La Roche Ltd.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 40
With the analysis among 180 patents, we discovered top 18 start-ups by total patent application. Histide AG, DRAGONFLY Therapeutics, Inc., Scorpion Therapeutics, Inc. are active in this area.
Schwyz, Switzerland
Patent: 91
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 18
Scorpion Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Institut National de la Santé et de la Recherche Médicale
Washington, United States
Patent: 10
New York, United States
Patent: 8
ZetaGen Therapeutics, Inc.
New York, United States
Patent: 5
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 4
Seurat Therapeutics, Inc.
Illinois, United States
Patent: 4
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 3
With the analysis among related 618 patents applied in the last 5 years. We discover 207 most active companies in this area. The fast-growing Yuhan Corp., Histide AG, AstraZeneca Pharmaceutical Co., Ltd. take 16.02% of patent filing during this period.
Schwyz, Switzerland
Patent: 21
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 21
Utrecht, Netherlands
Patent: 19
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 18
Zakrytoe Aktsionernoe Obshchestvo Biokad
Scorpion Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Spectrum Pharmaceuticals, Inc.
Nevada, United States
Patent: 13
Chong Kun Dang Pharmaceutical Corp.
With the analysis among related 618 patents in last 5 years, we discover 116 new entrants. DRAGONFLY Therapeutics, Inc., Zakrytoe Aktsionernoe Obshchestvo Biokad, Scorpion Therapeutics, Inc. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 18
Zakrytoe Aktsionernoe Obshchestvo Biokad
Scorpion Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Spectrum Pharmaceuticals, Inc.
Nevada, United States
Patent: 13
Chong Kun Dang Pharmaceutical Corp.
Washington, United States
Patent: 10
Chengdu Bailidote Biological Pharmaceutical Co., Ltd.
Mitsubishi Tanabe Pharma Corp.
New York, United States
Patent: 8
Wigen Biomedicine technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 6
With the analysis among 786 patents, we discovered top 115 universities and scientific research institutions by total patent application. Shenyang Pharmaceutical University, Georgetown University School of Medicine, Kyoto University are dominant in this area. They take 21.25% of the total patent filing.
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 16
Georgetown University School of Medicine
District of Columbia, United States
Patent: 16
Kyoto-fu, Japan
Patent: 13
Washington, United States
Patent: 12
The University of Chicago
Illinois, United States
Patent: 10
Thomas Jefferson University
Pennsylvania, United States
Patent: 10
Queensland University of Technology
Queensland, Australia
Patent: 10
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 9
Washington University in St. Louis
Missouri, United States
Patent: 9
Miyagi-ken, Japan
Patent: 9